Trial Profile
A multiple-ascending dose phase I study of NKTR-171 in healthy volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs NKTR-171 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Nektar Therapeutics
- 03 Nov 2015 New trial record